Citi raised the firm’s price target on GE HealthCare (GEHC) to $89 from $86 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare to present portfolio of precision care at SNMMI
- Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization
- GE Healthcare Issues $1.5 Billion in Senior Notes
- GE Healthcare Announces $1.5 Billion Notes Offering
- GE HealthCare announces NCCN Guidelines recommend use of FES PET imaging